Sun Pharma Advanced Research Company Limited (BOM:532872)
India · Delayed Price · Currency is INR 134.95
-1.95 (-1.42%)
At close: Feb 12, 2026
BOM:532872 Statistics
Total Valuation
BOM:532872 has a market cap or net worth of INR 42.87 billion. The enterprise value is 47.03 billion.
| Market Cap | 42.87B |
| Enterprise Value | 47.03B |
Important Dates
The last earnings date was Monday, February 9, 2026.
| Earnings Date | Feb 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 324.52M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 25.75% |
| Owned by Institutions (%) | 6.55% |
| Float | 91.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 80.68 |
| PB Ratio | -12.44 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -17.55 |
| EV / Sales | 88.50 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.95 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -308.73% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.68M |
| Profits Per Employee | -8.48M |
| Employee Count | 316 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -7.12M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.66% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -7.66% |
| 50-Day Moving Average | 135.15 |
| 200-Day Moving Average | 144.47 |
| Relative Strength Index (RSI) | 46.02 |
| Average Volume (20 Days) | 103,289 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532872 had revenue of INR 531.36 million and -2.68 billion in losses. Loss per share was -8.25.
| Revenue | 531.36M |
| Gross Profit | 219.16M |
| Operating Income | -2.37B |
| Pretax Income | -2.69B |
| Net Income | -2.68B |
| EBITDA | -2.28B |
| EBIT | -2.37B |
| Loss Per Share | -8.25 |
Balance Sheet
The company has 9.40 million in cash and 4.17 billion in debt, with a net cash position of -4.16 billion.
| Cash & Cash Equivalents | 9.40M |
| Total Debt | 4.17B |
| Net Cash | -4.16B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -3.45B |
| Book Value Per Share | -10.63 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 41.25% |
| Operating Margin | -445.29% |
| Pretax Margin | -505.54% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOM:532872 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.02% |
| Shareholder Yield | -0.02% |
| Earnings Yield | -6.25% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |